JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein ninein

Molecular and Cellular Biology

Volumn 35, Issue 1, 2015, Pages 111-131

  Jay, Jennifer ^a   Hammer, Alan ^a   Nestor Kalinoski, Andrea ^a   Diakonova, Maria ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; JANUS KINASE 2; MEMBRANE PROTEIN; NINEIN; PROLACTIN; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; JAK2 PROTEIN, HUMAN; NIN PROTEIN, HUMAN; NUCLEAR PROTEIN;

AMINO TERMINAL SEQUENCE; ANAPHASE; ARTICLE; AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CENTRIOLE; CENTROMERE; CENTROSOME; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; COS 7 CELL LINE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; GENOMIC INSTABILITY; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; METAPHASE CHROMOSOME; MICROTUBULE; MITOSIS; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; ULTRASTRUCTURE;

ANIMALS; CENTRIOLES; CENTROSOME; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERON-GAMMA; JANUS KINASE 2; MICROTUBULES; MITOSIS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROLACTIN; PROTEIN STRUCTURE, TERTIARY;

EID: 84919953760     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01138-14     Document Type: Article

References (92)

1. Ihle JN, Gilliland DG. 2007. Jak2: normal function and role in hematopoietic disorders. Curr Opin Genet Dev 17:8-14. http://dx.doi.org/10.1016/j.gde.2006.12.009.
2. Hoeller S, Walz C, Reiter A, Dirnhofer S, Tzankov A. 2011. PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms. Expert Opin Ther Targets 15:53-62. http://dx.doi.org/10.1517/14728222.2011.538683.
3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. 2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779-1790. http://dx.doi.org/10.1056/NEJMoa051113.
4. Tefferi A, Gilliland DG. 2005. JAK2 in myeloproliferative disorders is not just another kinase. Cell Cycle 4:1053-1056. http://dx.doi.org/10.4161/cc.4.8.1872.
5. Constantinescu SN, Girardot M, Pecquet C. 2008. Mining for JAK-STAT mutations in cancer. Trends Biochem Sci 33:122-131. http://dx.doi.org/10.1016/j.tibs.2007.12.002.
6. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309-1312. http://dx.doi.org/10.1126/science.278.5341.1309.
7. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptorassociated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15:12) in a myeloid leukemia. Blood 90:2535-2540.
8. Griesinger F, Hennig H, Hillmer F, Podleschny M, Steffens R, Pies A, Wormann B, Haase D, Bohlander SK. 2005. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia. Genes Chromosomes Cancer 44:329-333. http://dx.doi.org/10.1002/gcc.20235.
9. Reiter A, Walz C, Watmore A, Schoch C, Blau I, Schlegelberger B, Berger U, Telford N, Aruliah S, Yin JA, Vanstraelen D, Barker HF, Taylor PC, O'Driscoll A, Benedetti F, Rudolph C, Kolb HJ, Hochhaus A, Hehlmann R, Chase A, Cross NC. 2005. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 65:2662-2667. http://dx.doi.org/10.1158/0008-5472.CAN-04-4263.
10. Murati A, Gelsi-Boyer V, Adelaide J, Perot C, Talmant P, Giraudier S, Lode L, Letessier A, Delaval B, Brunel V, Imbert M, Garand R, Xerri L, Birnbaum D, Mozziconacci MJ, Chaffanet M. 2005. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia 19:1692-1696. http://dx.doi.org/10.1038/sj.leu.2403879.
11. Bousquet M, Quelen C, De Mas V, Duchayne E, Roquefeuil B, Delsol G, Laurent G, Dastugue N, Brousset P. 2005. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 24:7248-7252. http://dx.doi.org/10.1038/sj.onc.1208850.
12. Delaval B, Lelievre H, Birnbaum D. 2005. Myeloproliferative disorders: the centrosome connection. Leukemia 19:1739-1744. http://dx.doi.org/10.1038/sj.leu.2403926.
13. Behrmann I, Smyczek T, Heinrich PC, Schmitz-Van de Leur H, Komyod W, Giese B, Muller-Newen G, Haan S, Haan C. 2004. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak. receptor complex to be equivalent to a receptor tyrosine kinase. J Biol Chem 279:35486-35493. http://dx.doi.org/10.1074/jbc. M404202200.
14. Lee S, Duhe RJ. 2006. Kinase activity and subcellular distribution of a chimeric green fluorescent protein-tagged Janus kinase 2. J Biomed Sci 13:773-786. http://dx.doi.org/10.1007/s11373-006-9111-9.
15. Ram PA, Waxman DJ. 1997. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272:17694-17702. http://dx.doi.org/10.1074/jbc.272.28.17694.
16. Moulin S, Bouzinba-Segard H, Kelly PA, Finidori J. 2003. Subcellular trafficking of growth hormone receptor and Jak2 under ligand exposure. Hormone Metab Res 35:396-401. http://dx.doi.org/10.1055/s -2003-41619.
17. Nilsson J, Bjursell G, Kannius-Janson M. 2006. Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells. Mol Cell Biol 26:5663-5674. http://dx.doi.org/10.1128/MCB.02095-05.
18. Lavoie C, Chevet E, Roy L, Tonks NK, Fazel A, Posner BI, Paiement J, Bergeron JJ. 2000. Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro. Proc Natl Acad Sci U S A 97: 13637-13642. http://dx.doi.org/10.1073/pnas.240278097.
19. Lobie PE, Ronsin B, Silvennoinen O, Haldosen LA, Norstedt G, Morel G. 1996. Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology 137:4037-4045. http://dx.doi.org/10.1210/endo.137.9.8756581.
20. Sorenson RL, Stout LE. 1995. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology 136:4092-4098. http://dx.doi.org/10.1210/endo.136.9.7649117.
21. Rinaldi CR, Rinaldi P, Alagia A, Gemei M, Esposito N, Formiggini F, Martinelli V, Senyuk V, Nucifora G, Pane F. 2010. Preferential nuclear accumulation of JAK2V617F in CD34 but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. Blood 116:6023-6026. http://dx.doi.org/10.1182/blood-2010-08-302265.
22. Dawson MA, Bannister AJ, Saunders L, Wahab OA, Liu F, Nimer SD, Levine RL, Gottgens B, Kouzarides T, Green AR. 2011. Nuclear JAK2. Blood 118:6987-6988. http://dx.doi.org/10.1182/blood-2011-10-385278.
23. Girodon F, Steinkamp MP, Cleyrat C, Hermouet S, Wilson BS. 2011. Confocal imaging studies cast doubt on nuclear localization of JAK2V617F. Blood 118:2633-2634. http://dx.doi.org/10.1182/blood -2011-02-336479.
24. Ma X, Sayeski PP. 2007. Identification of tubulin as a substrate of Jak2 tyrosine kinase and its role in Jak2-dependent signaling. Biochemistry 46:7153-7162. http://dx.doi.org/10.1021/bi700101n.
25. Vorobjev IA, Chentsov Yu S. 1982. Centrioles in the cell cycle. I. Epithelial cells. J Cell Biol 93:938-949.
26. Paintrand M, Moudjou M, Delacroix H, Bornens M. 1992. Centrosome organization and centriole architecture: their sensitivity to divalent cations. J Struct Biol 108:107-128. http://dx.doi.org/10.1016/1047-8477(92)90011-X.
27. Robbins E, Jentzsch G, Micali A. 1968. The centriole cycle in synchronized HeLa cells. J Cell Biol 36:329-339. http://dx.doi.org/10.1083/jcb.36.2.329.
28. Gorgidze LA, Vorobjev IA. 1995. Centrosome and microtubules behavior in the cytoplasts. J Submicrosc Cytol Pathol 27:381-389.
29. De Brabander M. 1982. A model for the microtubule organizing activity of the centrosomes and kinetochores in mammalian cells. Cell Biol Int Rep 6:901-915. http://dx.doi.org/10.1016/0309-1651(82)90001-7.
30. Delgehyr N, Sillibourne J, Bornens M. 2005. Microtubule nucleation and anchoring at the centrosome are independent processes linked by ninein function. J Cell Sci 118:1565-1575. http://dx.doi.org/10.1242/jcs.02302.
31. Ibrahim R, Messaoudi C, Chichon FJ, Celati C, Marco S. 2009. Electron tomography study of isolated human centrioles. Microsc Res Tech 72:42-48. http://dx.doi.org/10.1002/jemt.20637.
32. Bouckson-Castaing V, Moudjou M, Ferguson DJ, Mucklow S, Belkaid Y, Milon G, Crocker PR. 1996. Molecular characterisation of ninein, a new coiled-coil protein of the centrosome. J Cell Sci 109:179-190.
33. Mogensen MM, Malik A, Piel M, Bouckson-Castaing V, Bornens M. 2000. Microtubule minus-end anchorage at centrosomal and noncentrosomal sites: the role of ninein. J Cell Sci 113:3013-3023.
34. Piel M, Meyer P, Khodjakov A, Rieder CL, Bornens M. 2000. The respective contributions of the mother and daughter centrioles to centro- some activity and behavior in vertebrate cells. J Cell Biol 149:317-330. http://dx.doi.org/10.1083/jcb.149.2.317.
35. Ou YY, Mack GJ, Zhang M, Rattner JB. 2002. CEP110 and ninein are located in a specific domain of the centrosome associated with centrosome maturation. J Cell Sci 115:1825-1835.
36. Howng SL, Hsu HC, Cheng TS, Lee YL, Chang LK, Lu PJ, Hong YR. 2004. A novel ninein-interaction protein, CGI-99, blocks ninein phosphorylation by GSK3beta and is highly expressed in brain tumors. FEBS Lett 566:162-168. http://dx.doi.org/10.1016/j.febslet.2004.04.024.
37. Cheng TS, Hsiao YL, Lin CC, Hsu CM, Chang MS, Lee CI, Yu RC, Huang CY, Howng SL, Hong YR. 2007. hNinein is required for targeting spindle-associated protein Astrin to the centrosome during the S and G2 phases. Exp Cell Res 313:1710-1721. http://dx.doi.org/10.1016/j.yexcr.2007.02.023.
38. Chen CH, Howng SL, Cheng TS, Chou MH, Huang CY, Hong YR. 2003. Molecular characterization of human ninein protein: two distinct subdomains required for centrosomal targeting and regulating signals in cell cycle. Biochem Biophys Res Commun 308:975-983. http://dx.doi.org/10.1016/S0006-291X(03)01510-9.
39. Hong YR, Chen CH, Chuo MH, Liou SY, Howng SL. 2000. Genomic organization and molecular characterization of the human ninein gene. Biochem Biophys Res Commun 279:989-995. http://dx.doi.org/10.1006/bbrc.2000.4050.
40. Cheng TS, Chang LK, Howng SL, Lu PJ, Lee CI, Hong YR. 2006. SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. Life Sci 78:1114-1120. http://dx.doi.org/10.1016/j.lfs.2005.06.021.
41. Lange BM. 2002. Integration of the centrosome in cell cycle control, stress response and signal transduction pathways. Curr Opin Cell Biol 14:35-43. http://dx.doi.org/10.1016/S0955-0674(01)00291-5.
42. Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. 1998. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci U S A 95:2950-2955. http://dx.doi.org/10.1073/pnas.95.6.2950.
43. Chretien D, Buendia B, Fuller SD, Karsenti E. 1997. Reconstruction of the centrosome cycle from cryoelectron micrographs. J Struct Biol 120: 117-133. http://dx.doi.org/10.1006/jsbi.1997.3928.
44. Doxsey S, Zimmerman W, Mikule K. 2005. Centrosome control of the cell cycle. Trends Cell Biol 15:303-311. http://dx.doi.org/10.1016/j.tcb.2005.04.008.
45. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, et al. 1993. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366:166-170. http://dx.doi.org/10.1038/366166a0.
46. Kohlhuber F, Rogers NC, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn BA, Kotenko SV, Pestka S, Stark GR, Ihle JN, Kerr IM. 1997. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol 17:695-706.
47. Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers MG, Jr. 2002. Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 277:41547-41555. http://dx.doi.org/10.1074/jbc. M205148200.
48. Robertson SA, Koleva RI, Argetsinger LS, Carter-Su C, Marto JA, Feener EP, Myers MG, Jr. 2009. Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Mol Cell Biol 29:3367-3378. http://dx.doi.org/10.1128/MCB.00278-09.
49. Zhao L, Ma Y, Seemann J, Huang LJ. 2010. A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F). Biochem J 426:91-98. http://dx.doi.org/10.1042/BJ20090615.
50. Rui L, Carter-Su C. 1999. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci U S A 96:7172-7177. http://dx.doi.org/10.1073/pnas.96.13.7172.
51. Moudjou M, Bornens M. 1994. Method of centrosome isolation from cultured animal cells, p 595-604. In J.E. Célis (ed), Cell biology: A laboratory handbook. Academic Press, San Diego, CA.
52. Paoletti A, Moudjou M, Paintrand M, Salisbury JL, Bornens M. 1996. Most of centrin in animal cells is not centrosome-associated and centrosomal centrin is confined to the distal lumen of centrioles. J Cell Sci 109: 3089-3102.
53. La Terra S, English CN, Hergert P, McEwen BF, Sluder G, Khodjakov A. 2005. The de novo centriole assembly pathway in HeLa cells: cell cycle progression and centriole assembly/maturation. J Cell Biol 168:713-722. http://dx.doi.org/10.1083/jcb.200411126.
54. Keating TJ, Peloquin JG, Rodionov VI, Momcilovic D, Borisy GG. 1997. Microtubule release from the centrosome. Proc Natl Acad Sci U S A 94:5078-5083. http://dx.doi.org/10.1073/pnas.94.10.5078.
55. Bartolini F, Gundersen GG. 2006. Generation of noncentrosomal microtubule arrays. J Cell Sci 119:4155-4163. http://dx.doi.org/10.1242/jcs.03227.
56. Lin CC, Cheng TS, Hsu CM, Wu CH, Chang LS, Shen ZS, Yeh HM, Chang LK, Howng SL, Hong YR. 2006. Characterization and functional aspects of human ninein isoforms that regulated by centrosomal targeting signals and evidence for docking sites to direct gamma-tubulin. Cell Cycle 5:2517-2527. http://dx.doi.org/10.4161/cc.5.21.3404.
57. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. 1996. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 16:6985-6992.
58. Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C. 1997. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol 17:6633-6644.
59. Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D, Decker T. 1996. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol 16:6937-6944.
60. Woldman I, Varinou L, Ramsauer K, Rapp B, Decker T. 2001. The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3. J Biol Chem 276:45722-45728. http://dx.doi.org/10.1074/jbc. M105320200.
61. Burdeinick-Kerr R, Govindarajan D, Griffin DE. 2009. Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol 83:3429-3435. http://dx.doi.org/10.1128/JVI.02381-08.
62. Ganem NJ, Godinho SA, Pellman D. 2009. A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278-282. http://dx.doi.org/10.1038/nature08136.
63. Silkworth WT, Nardi IK, Scholl LM, Cimini D. 2009. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS One 4:e6564. http://dx.doi.org/10.1371/journal.pone.0006564.
64. Gisselsson D, Bjork J, Hoglund M, Mertens F, Dal Cin P, Akerman M, Mandahl N. 2001. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 158:199-206. http://dx.doi.org/10.1016/S0002-9440(10)63958-2.
65. Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM, Saunders WS. 2004. Resolution of anaphase bridges in cancer cells. Chromosoma 112: 389-397. http://dx.doi.org/10.1007/s00412-004-0284-6.
66. Montgomery E, Wilentz RE, Argani P, Fisher C, Hruban RH, Kern SE, Lengauer C. 2003. Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignancies. Cancer Biol Ther 2:248-252.
67. Rajagopalan H, Lengauer C. 2004. Aneuploidy and cancer. Nature 432: 338-341. http://dx.doi.org/10.1038/nature03099.
68. Sandberg EM, Wallace TA, Godeny MD, VonDerLinden D, Sayeski PP. 2004. Jak2 tyrosine kinase: a true jak of all trades? Cell Biochem Biophys 41:207-232. http://dx.doi.org/10.1385/CBB:41:2:207.
69. Nogales-Cadenas R, Abascal F, Diez-Perez J, Carazo JM, Pascual- Montano A. 2009. CentrosomeDB: a human centrosomal proteins database. Nucleic Acids Res 37:D175-D180. http://dx.doi.org/10.1093/nar/gkn815.
70. Ren J, Liu Z, Gao X, Jin C, Ye M, Zou H, Wen L, Zhang Z, Xue Y, Yao X. 2010. MiCroKit 3.0: an integrated database of midbody, centrosome and kinetochore. Nucleic Acids Res 38:D155-D160. http://dx.doi.org/10.1093/nar/gkp784.
71. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. 2003. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426:570-574. http://dx.doi.org/10.1038/nature02166.
72. Jakobsen L, Vanselow K, Skogs M, Toyoda Y, Lundberg E, Poser I, Falkenby LG, Bennetzen M, Westendorf J, Nigg EA, Uhlen M, Hyman AA, Andersen JS. 2011. Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods. EMBO J 30:1520-1535. http://dx.doi.org/10.1038/emboj.2011.63.
73. Habermann K, Lange BM. 2012. New insights into subcomplex assembly and modifications of centrosomal proteins. Cell Div 7:17. http://dx.doi.org/10.1186/1747-1028-7-17.
74. Doxsey S, McCollum D, Theurkauf W. 2005. Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 21:411-434. http://dx.doi.org/10.1146/annurev.cellbio.21.122303.120418.
75. Sluder G. 2005. Two-way traffic: centrosomes and the cell cycle. Nature Rev Mol Cell Biol 6:743-748. http://dx.doi.org/10.1038/nrm1712.
76. Nigg EA, Stearns T. 2011. The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol 13:1154-1160. http://dx.doi.org/10.1038/ncb2345.
77. Delaval B, Letard S, Lelievre H, Chevrier V, Daviet L, Dubreuil P, Birnbaum D. 2005. Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome. Cancer Res 65:7231-7240. http://dx.doi.org/10.1158/0008-5472.CAN-04-4167.
78. Faruki S, Geahlen RL, Asai DJ. 2000. Syk-dependent phosphorylation of microtubules in activated B-lymphocytes. J Cell Sci 113:2557-2565.
79. Takahashi S, Inatome R, Hotta A, Qin Q, Hackenmiller R, Simon MC, Yamamura H, Yanagi S. 2003. Role for Fes/Fps tyrosine kinase in microtubule nucleation through its Fes/CIP4 homology domain. J Biol Chem 278:49129-49133. http://dx.doi.org/10.1074/jbc. C300289200.
80. Steindler C, Li Z, Algarte M, Alcover A, Libri V, Ragimbeau J, Pellegrini S. 2004. Jamip1 (marlin-1) defines a family of proteins interacting with janus kinases and microtubules. J Biol Chem 279:43168-43177. http://dx.doi.org/10.1074/jbc. M401915200.
81. Lieu AS, Cheng TS, Chou CH, Wu CH, Hsu CY, Huang CY, Chang LK, Loh JK, Chang CS, Hsu CM, Howng SL, Hong YR. 2010. Functional characterization of AIBp, a novel Aurora-A binding protein in centrosome structure and spindle formation. Int J Oncol 37:429-436. http://dx.doi.org/10.3892/ijo_00000691.
82. Matsumoto T, Schiller P, Dieterich LC, Bahram F, Iribe Y, Hellman U, Wikner C, Chan G, Claesson-Welsh L, Dimberg A. 2008. Ninein is expressed in the cytoplasm of angiogenic tip-cells and regulates tubular morphogenesis of endothelial cells. Arterioscler Thromb Vasc Biol 28: 2123-2130. http://dx.doi.org/10.1161/ATVBAHA.108.169128.
83. Maures TJ, Kurzer JH, Carter-Su C. 2007. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. Trends Endocrinol Metab 18:38-45. http://dx.doi.org/10.1016/j.tem.2006.11.007.
84. Metge B, Ofori-Acquah S, Stevens T, Balczon R. 2004. Stat3 activity is required for centrosome duplication in chinese hamster ovary cells. J Biol Chem 279:41801-41806. http://dx.doi.org/10.1074/jbc. M407094200.
85. Vuong BQ, Arenzana TL, Showalter BM, Losman J, Chen XP, Mostecki J, Banks AS, Limnander A, Fernandez N, Rothman PB. 2004. SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome. Mol Cell Biol 24:9092-9101. http://dx.doi.org/10.1128/MCB.24.20.9092-9101.2004.
86. Takaoka A, Tanaka N, Mitani Y, Miyazaki T, Fujii H, Sato M, Kovarik P, Decker T, Schlessinger J, Taniguchi T. 1999. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFNgamma, but not IFN-alpha, signaling. EMBO J 18:2480-2488. http://dx.doi.org/10.1093/emboj/18.9.2480.
87. Ley SC, Marsh M, Bebbington CR, Proudfoot K, Jordan P. 1994. Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes. J Cell Biol 125:639-649. http://dx.doi.org/10.1083/jcb.125.3.639.
88. Kapeller R, Chakrabarti R, Cantley L, Fay F, Corvera S. 1993. Internalization of activated platelet-derived growth factor receptorphosphatidylinositol- 3= kinase complexes: potential interactions with the microtubule cytoskeleton. Mol Cell Biol 13:6052-6063.
89. Herrmann L, Dittmar T, Erdmann KS. 2003. The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. Mol Biol Cell 14:230-240. http://dx.doi.org/10.1091/mbc. E02-04-0191.
90. Hsu LC, White RL. 1998. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 95:12983-12988. http://dx.doi.org/10.1073/pnas.95.22.12983.
91. Vizmanos JL, Novo FJ, Roman JP, Baxter EJ, Lahortiga I, Larrayoz MJ, Odero MD, Giraldo P, Calasanz MJ, Cross NC. 2004. NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Cancer Res 64:2673-2676. http://dx.doi.org/10.1158/0008-5472.CAN-04-0144.
92. Plo I, Nakatake M, Malivert L, de Villartay JP, Giraudier S, Villeval JL, Wiesmuller L, Vainchenker W. 2008. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood 112:1402-1412. http://dx.doi.org/10.1182/blood-2008-01-134114.